Bayer’s Betaferon Extends MS Patients’ Lives, Study Finds

Bayer AG’s betaferon multiple sclerosis treatment helped patients live longer when taken soon after the onset of the disease in a study researchers said is the first to show such a drug extends patients’ lives.
Bloomberg